TIMELINE

01-02-2018

February 2018

Showcase HbA1c device for the first time at Advanced Technologies & Treatments for Diabetes (ATTD), Vienna, Austria

01-01-2018

January 2018

First clinical trials begin at San Raffaele Hospital, Milan, Italy

01-12-2017

December 2017

‘Top Presenting Company’ at Tech Tour 2017 European Venture Contest (EVC) Final, Dusseldorf, Germany

01-11-2017

November 2017

Winner at BigBooster Camp, Lyon - qualify for next round

01-10-2017

October 2017

Rank among top five start-ups at the Italian Healthcare Venture Forum, Turin, Italy

01-10-2017

October 2017

Rank among top 10 start-ups at Alpine High-Tech Venture Forum, Lausanne, Switzerland - qualify for Tech Tour 2017 European Venture Contest (EVC) Final

01-09-2017

September 2017

Configure final chip prototype, commence production and full characterization testing

01-07-2017

July 2017

Announce Clinical Advisory Board  

01-06-2017

June 2017

Present at the Venture 5i event, Grenoble, France

01-06-2017

June 2017

Attend American Diabetes Association (ADA) Congress, San Diego, USA

01-07-2016

July 2016

Receive €2m grant from European Commission (Horizon 2020)

2013-2015

Begin assay and technology development, develop first prototype and conduct chip fabrication processes